da Silva Regina Cintra Querino, Miranda Walkiria Lopes, Chacra Antonio Roberto, Dib Sérgio Atala
Diabetes Center of Universidade Federal de São Paulo, São Paulo, Brazil.
J Diabetes Complications. 2007 Mar-Apr;21(2):84-92. doi: 10.1016/j.jdiacomp.2005.11.006.
To evaluate insulin resistance (IR), beta-cell function, and glucose tolerance in 119 Brazilian adolescents with obesity or risk factors (RF) for type 2 diabetes mellitus (T2DM).
We analyzed weight (kg), height (m), body mass index (BMI; kg/m(2)), waist (W; cm), acanthosis nigricans (AN), systolic and diastolic blood pressure (SBP and DBP; mm Hg), fasting plasma glucose (FPG), and 2-h plasma glucose (2hPG) on oral glucose tolerance test (OGTT; 1.75 g of glucose/weight), lipid profile [total cholesterol (TC), fractions, and triglycerides (TGs)], fasting insulin (FI) and 2-h insulin on OGTT (2hI-RIA), HOMA-B (%; beta-cell function--HOMA program), HOMA-S (%; insulin sensitivity--HOMA program) and HOMA-IR [fasting plasma insulin (mU/ml)xfasting plasma glucose (mmol/L)/22.5]. Division according to number of RF-family history of T2DM (FHT2DM), obesity, hypertension, dyslipidemia, polycystic ovary syndrome (PCOS), and AN. G1: subjects with no or one RF; G2: subjects with two or more RFs. Statistical data were nonparametrical.
Fasting plasma glucose (G2: 81.6+/-10.2 vs. G1: 79.8+/-9.9 mg/dl) and 2hPG (88.1+/-18.0 vs. 87.0+/-19.9 mg/dl) were not different between G2 (n=67) and G1 (n=52), and all adolescents had normal glucose tolerance (NGT). Fasting insulin (13.0+/-7.9 vs. 7.6+/-3.9 microIU/ml; P<.001) and 2hI (60.2+/-39.1 vs. 38.3+/-40.0 microIU/ml; P<.001), HOMA-B (169.1+/-131.6% vs. 106.1+/-39.9%; P<.001), and HOMA-IR (2.62+/-1.7 vs. 1.52+/-0.8; P<.001) were higher in G2. HOMA-S (92.5+/-59.5% vs. 152.2+/-100.5%; P<.001) was also lower in this latter group.
Brazilian adolescents with two or more RFs for the development of T2DM have higher IR and beta-cell function and lower insulin sensitivity. However, adolescents with impaired glucose tolerance (IGT) or DM have not been found, differently from similar studies. Differences in ethnic background, environment, and lifestyle factors may account for this disparity.
评估119名患有肥胖症或有2型糖尿病(T2DM)风险因素(RF)的巴西青少年的胰岛素抵抗(IR)、β细胞功能和葡萄糖耐量。
我们分析了体重(kg)、身高(m)、体重指数(BMI;kg/m²)、腰围(W;cm)、黑棘皮症(AN)、收缩压和舒张压(SBP和DBP;mmHg)、空腹血糖(FPG)以及口服葡萄糖耐量试验(OGTT;1.75g葡萄糖/体重)中的2小时血糖(2hPG)、血脂谱[总胆固醇(TC)、各组分及甘油三酯(TGs)]、空腹胰岛素(FI)和OGTT中的2小时胰岛素(2hI-RIA)、HOMA-B(%;β细胞功能——HOMA程序)、HOMA-S(%;胰岛素敏感性——HOMA程序)以及HOMA-IR[空腹血浆胰岛素(mU/ml)×空腹血浆葡萄糖(mmol/L)/22.5]。根据T2DM家族史(FHT2DM)、肥胖、高血压、血脂异常、多囊卵巢综合征(PCOS)和AN等RF的数量进行分组。G1:无RF或有一个RF的受试者;G2:有两个或更多RF的受试者。统计数据采用非参数检验。
G2组(n=67)和G1组(n=52)之间的空腹血糖(G2:81.6±10.2 vs. G1:79.8±9.9mg/dl)和2hPG(88.1±18.0 vs. 87.0±19.9mg/dl)无差异,所有青少年的葡萄糖耐量均正常(NGT)。G2组的空腹胰岛素(13.0±7.9 vs. 7.6±3.9μIU/ml;P<0.001)、2hI(60.2±39.1 vs. 38.3±40.0μIU/ml;P<0.001)、HOMA-B(169.1±131.6% vs. 106.1±39.9%;P<0.001)和HOMA-IR(2.62±1.7 vs. 1.52±0.8;P<0.001)更高。后一组的HOMA-S(92.5±59.5% vs. 152.2±100.5%;P<0.001)也更低。
有两个或更多T2DM发生RF的巴西青少年具有更高的IR和β细胞功能以及更低的胰岛素敏感性。然而,与类似研究不同,未发现葡萄糖耐量受损(IGT)或糖尿病的青少年。种族背景、环境和生活方式因素的差异可能解释了这种差异。